A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of Type 1 diabetes in NOD mice

To prepare a novel Bispecific Antibody (BsAb) as a potential targeted therapy for T1D, we produced a “functionally inert” monoclonal antibody (mAb) against Glucose transporter-2 (GLUT-2) expressed on β-cells to serve as an anchoring antibody. The therapeutic arm is an agonistic mAb against Cytotoxic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bhattacharya, Palash, Fan, Jilao, Haddad, Christine, Essani, Abdul, Gopisetty, Anupama, Elshabrawy, Hatem A, Vasu, Chenthamarakshan, Prabhakar, Bellur S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077286/
https://ncbi.nlm.nih.gov/pubmed/24792135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2014.04.014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares